It was shown in post-mortem brain samples that Cdc42 expression was upregulated in AD patients; thus, this potential loss of polarity could contribute to YAP activation and thus increase pro-inflammatory cytokines, contributing to the progression of AD [82]. The gene discussed is YAP1; the disease is Alzheimer disease.